Glycogen storage disease due to glucose-6-phosphate transport defect (Q100839): Difference between revisions

From determinar.ia.br - Determine suas informações
‎Created a new Item
 
‎Changed label, description and/or aliases in pt-br, en
description / pt-brdescription / pt-br
 
A glicogenose por deficiência de glicose-6-fosfatase (G6P) tipo a, ou doença do armazenamento de glicogênio (GSD) tipo 1a, é um tipo de glicogenose por deficiência de G6P que pode se manifestar ao nascimento por hepatomegalia ou mais comumente, entre a idade de três a quatro meses, por sintomas de hipoglicemia induzida por jejum (tremores, convulsões, cianose e apneia), devido ao distúrbio da homeostase da glicose.
description / endescription / en
 
Glycogenosis due to glucose-6-phosphatase deficiency (G6P) type a, or glycogen storage disease (GSD) type 1a, is a type of glycogenosis due to G6P deficiency that may manifest at birth by enlarged liver or, more commonly, between the ages of three to four months by symptoms of fast-induced hypoglycaemia (tremors, seizures, cyanosis, and apnoea) as a result of disturbed glucose homeostasis .

Revision as of 17:36, 16 August 2026

Glycogenosis due to glucose-6-phosphatase deficiency (G6P) type a, or glycogen storage disease (GSD) type 1a, is a type of glycogenosis due to G6P deficiency that may manifest at birth by enlarged liver or, more commonly, between the ages of three to four months by symptoms of fast-induced hypoglycaemia (tremors, seizures, cyanosis, and apnoea) as a result of disturbed glucose homeostasis .
Language Label Description Also known as
default for all languages
ID_1944306590
    English
    Glycogen storage disease due to glucose-6-phosphate transport defect
    Glycogenosis due to glucose-6-phosphatase deficiency (G6P) type a, or glycogen storage disease (GSD) type 1a, is a type of glycogenosis due to G6P deficiency that may manifest at birth by enlarged liver or, more commonly, between the ages of three to four months by symptoms of fast-induced hypoglycaemia (tremors, seizures, cyanosis, and apnoea) as a result of disturbed glucose homeostasis .

      Statements